These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24763078)

  • 1. Reasons for hospitalization in HIV-infected children in West Africa.
    Dicko F; Desmonde S; Koumakpai S; Dior-Mbodj H; Kouéta F; Baeta N; Koné N; Akakpo J; Signate Sy H; Ye D; Renner L; Lewden C; Leroy V;
    J Int AIDS Soc; 2014; 17(1):18818. PubMed ID: 24763078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.
    Lewden C; Drabo YJ; Zannou DM; Maiga MY; Minta DK; Sow PS; Akakpo J; Dabis F; Eholié SP;
    J Int AIDS Soc; 2014; 17(1):18797. PubMed ID: 24713375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaboration.
    Abo Y; Zannou Djimon M; Messou E; Balestre E; Kouakou M; Akakpo J; Ahouada C; de Rekeneire N; Dabis F; Lewden C; Minga A;
    BMC Infect Dis; 2015 Apr; 15():176. PubMed ID: 25885859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
    J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
    PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of malnutrition among HIV-infected children in Central and West-African HIV-care programmes supported by the Growing Up Programme in 2011: a cross-sectional study.
    Jesson J; Masson D; Adonon A; Tran C; Habarugira C; Zio R; Nicimpaye L; Desmonde S; Serurakuba G; Kwayep R; Sare E; Konate T; Nimaga A; Saina P; Kpade A; Bassuka A; Gougouyor G; Leroy V;
    BMC Infect Dis; 2015 May; 15():216. PubMed ID: 26007232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.
    Jesson J; Koumakpaï S; Diagne NR; Amorissani-Folquet M; Kouéta F; Aka A; Lawson-Evi K; Dicko F; Kouakou K; Pety T; Renner L; Eboua T; Coffie PA; Desmonde S; Leroy V;
    Pediatr Infect Dis J; 2015 Jul; 34(7):e159-68. PubMed ID: 25955835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
    Walker AS; Mulenga V; Ford D; Kabamba D; Sinyinza F; Kankasa C; Chintu C; Gibb DM;
    Clin Infect Dis; 2007 May; 44(10):1361-7. PubMed ID: 17443476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy.
    Collins IJ; Cairns J; Jourdain G; Fregonese F; Nantarukchaikul M; Lertpienthum N; Wannarit P; Attavinijtrakarn P; Layangool P; Le Coeur S; Lallemant M;
    AIDS; 2012 Sep; 26(15):1943-52. PubMed ID: 22824633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008.
    Ekouevi DK; Azondekon A; Dicko F; Malateste K; Touré P; Eboua FT; Kouadio K; Renner L; Peterson K; Dabis F; Sy HS; Leroy V;
    BMC Public Health; 2011 Jun; 11():519. PubMed ID: 21718505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
    Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
    BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia.
    Álvarez Barreneche MF; Restrepo Castro CA; Hidrón Botero A; Villa Franco JP; Trompa Romero IM; Restrepo Carvajal L; Eusse García A; Ocampo Mesa A; Echeverri Toro LM; Porras Fernández de Castro GP; Ramírez Rivera JM; Agudelo Restrepo CA
    AIDS Res Ther; 2017 Nov; 14(1):60. PubMed ID: 29132400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
    Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
    Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.
    Ekouevi DK; Balestre E; Coffie PA; Minta D; Messou E; Sawadogo A; Minga A; Sow PS; Bissagnene E; Eholie SP; Gottlieb GS; Dabis F; ; Zannou DM; Ahouada C; Akakpo J; Ahomadegbé C; Bashi J; Gougounon-Houéto A; Azon-Kouanou A; Houngbé F; Koumakpaï S; Alihonou F; d'Almeida M; Hodonou I; Hounhoui G; Sagbo G; Tossa-Bagnan L; Adjide H; Drabo J; Bognounou R; Dienderé A; Traore E; Zoungrana L; Zerbo B; Sawadogo AB; Zoungrana J; Héma A; Soré I; Bado G; Tapsoba A; Yé D; Kouéta F; Ouedraogo S; Ouédraogo R; Hiembo W; Gansonré M; Messou E; Gnokoro JC; Koné M; Kouakou GM; Bosse CA; Brou K; Assi AI; Chenal H; Hawerlander D; Soppi F; Minga A; Abo Y; Bomisso G; Eholié SP; Amego MD; Andavi V; Diallo Z; Ello F; Tanon AK; Koule SO; Anzan KC; Guehi C; Aka EA; Issouf KL; Kouakou JC; N'gbeche MS; Touré P; Avit-Edi D; Kouakou K; Moh M; Yao VA; Folquet MA; Dainguy ME; Kouakou C; Méa-Assande VT; Oka-Berete G; Zobo N; Acquah P; Kokora MB; Eboua TF; Timité-Konan M; Ahoussou LD; Assouan JK; Sami MF; Kouadio C; Renner L; Goka B; Welbeck J; Sackey A; Owiafe SN; Wejse C; Silva ZJ; Paulo J; Rodrigues A; da Silva D; Medina C; Oliviera-Souto I; Ostergaard L; Laursen A; Sodemann M; Aaby P; Fomsgaard A; Erikstrup C; Eugen-Olsen J; Maïga MY; Diakité FF; Kalle A; Katile D; Traore HA; Minta D; Cissé T; Dembelé M; Doumbia M; Fomba M; Kaya AS; Traoré AM; Traoré H; Toure AA; Dicko F; Sylla M; Berthé A; Traoré HC; Koïta A; Koné N; N'diaye C; Coulibaly ST; Traoré M; Traoré N; Charurat M; Ajayi S; Dapiap S; Otu ; Igbinoba F; Benson O; Adebamowo C; James J; Obaseki ; Osakede P; Olasode J; Sow PS; Diop B; Manga NM; Tine JM; Signate Sy H; Ba A; Diagne A; Dior H; Faye M; Gueye RD; Mbaye AD; Patassi A; Kotosso A; Kariyare BG; Gbadamassi G; Komi A; Mensah-Zukong KE; Pakpame P; Lawson-Evi AK; Atakouma Y; Takassi E; Djeha A; Ephoévi-Gah A; Djibril Sel-H; Dabis F; Bissagnene E; Arrivé E; Coffie P; Ekouevi D; Jaquet A; Leroy V; Lewden C; Sasco A; Azani JC; Allou G; Balestre E; Bohossou F; Karcher S; Gonsan JM; Carrou JL; Lenaud S; Nchot C; Malateste K; Yao AR; Siloué B; Clouet G; Djetouan H; Doring A; Kouakou A; Rabourdin E; Rivenc J; Anglaret X; Ba B; Essanin JB; Ciaranello A; Datté S; Desmonde S; Diby JS; Gottlieb GS; Horo AG; Kangah SN; Malvy D; Meless D; Mounkaila-Harouna A; Ndondoki C; Shiboski C; Thiébaut R; Pac-Ci ; Abidjan
    PLoS One; 2013; 8(6):e66135. PubMed ID: 23824279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
    Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
    J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
    Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
    J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count.
    De Beaudrap P; Boullé C; Lewden C; Gabillard D; Nacro B; Diagbouga S; Fassinou P; Hien H; Laurent C; Msellati P;
    Pediatr Infect Dis J; 2013 Apr; 32(4):354-60. PubMed ID: 23099424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort.
    Jesson J; Ephoevi-Ga A; Desmonde S; Ake-Assi MH; D'Almeida M; Sy HS; Malateste K; Amorissani-Folquet M; Dicko F; Kouadio K; Renner L; Leroy V;
    Trop Med Int Health; 2019 Jun; 24(6):775-785. PubMed ID: 30945378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) - A prospective HIV cohort in rural Tanzania.
    Letang E; Kalinjuma AV; Glass TR; Gamell A; Mapesi H; Sikalengo GR; Luwanda LB; Mnzava D; Ntamatungiro AJ; Ndaki R; Francis G; Vanobberghen F; Furrer H; Klimkait T; Felger I; Tanner M; Hatz C; Weisser M; Battegay M; Kiularco Study Group
    Swiss Med Wkly; 2017; 147():w14485. PubMed ID: 28695551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.